Navigation Links
UK Hospitals Failing Hygiene Standards

Hygiene is at a premium in advanced countries, it seems. Sometime ago a nurse in UK was found screaming at a heart attack patient who was left lying in a puddle of urine . And now it is reported that a quarter of NHS trusts are not complying with hygiene standards laid down for them.

However, the Healthcare Commission said 40% of trusts were meeting all core standards. This was up from 34% last year. In total there are 24 core NHS standards, covering everything from clinical effectivness to governance. England's 394 trusts self-declare how they are doing against the core standards, which then help determine their overall NHS rating.

The Healthcare Commission now has to verify the data by cross-checking the information against its own intelligence, audits and surveys by other organisations and through a system of targeted spot-checks. The rise in trusts reporting full compliance was also accompanied by a rise, from 74% to 85%, in those saying they are meeting 90% of the standards.

Trusts did best in meeting standards covering professional codes of practice, whistle-blowing and openness. There was also a rise in the number of trusts reporting they met the two standards relating to compliance with the National Institute for Health and Clinical Excellence, which issues advice on new treatments. But with the three standards that relate to hygiene, compliance had fallen.

In particular, on reducing the risk of infection, 14% said they had failed, up from 7% last year. A similar number said they could not say they decontaminated equipment properly - up from 12.6%. Over one in 10 did not meet cleanliness standards either. It meant that 99 trusts - one in four of the total - were not meeting the hygiene code.

Gill Morgan, chief executive of the NHS Confederation, said: "By recognising in an open and honest way that they need to do more, trusts are taking the important steps towards delivering excellen
'"/>




Page: 1 2

Related medicine news :

1. Apollo Hospitals to consider listing on US Bourses in 2003
2. Apollo Hospitals Collaborates With Histostem For Stem Cell Therapy
3. Indian Hospitals – A Destination For Quality Medical Care
4. Researchers Begin Study To Find Out If Angioplasty Can Be Safely Done In Smaller Hospitals
5. Quality Awareness In Hospitals Can Reduce Mortality Rate Of Patients
6. First PET-CT guided radiotherapy in India was performed by Apollo Hospitals
7. Delhi Government To Interlink All Major Hospitals Through e-Governance
8. Global Hospitals coming to city of Joy
9. Indias Hospitals Among The Best, Says Renuka Chowdhury
10. Apollo Hospitals Short-listed to Provide Diagnostics in the UK
11. Apollo Hospitals to invest Rs 350 cr to add 1,800 beds
Post Your Comments:
Breaking Medicine Technology:VidaySalud.com(TM) Reaches 1,000,000 Page Views In its First Six Months of Operation 2Keryx Biopharmaceuticals, Inc. Reports Updated Phase 1/2 Data, Including New Survival Data, on KRX-0401 (Perifosine) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 2Keryx Biopharmaceuticals, Inc. Reports Updated Phase 1/2 Data, Including New Survival Data, on KRX-0401 (Perifosine) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 3Keryx Biopharmaceuticals, Inc. Reports Updated Phase 1/2 Data, Including New Survival Data, on KRX-0401 (Perifosine) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 4Keryx Biopharmaceuticals, Inc. Reports Updated Phase 1/2 Data, Including New Survival Data, on KRX-0401 (Perifosine) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 5Keryx Biopharmaceuticals, Inc. Reports Updated Phase 1/2 Data, Including New Survival Data, on KRX-0401 (Perifosine) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 6Keryx Biopharmaceuticals, Inc. Reports Updated Phase 1/2 Data, Including New Survival Data, on KRX-0401 (Perifosine) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 7Elusys Presents Data From Anthim(R) Anthrax Anti-Toxin Studies at the HHS Stakeholders Workshop 2009 & BARDA Industry Day 2Elusys Presents Data From Anthim(R) Anthrax Anti-Toxin Studies at the HHS Stakeholders Workshop 2009 & BARDA Industry Day 3Cosmetic Bootcamp University New York Deemed A Huge Success 59289 1Noninvasive Medical Technologies Supports 824 Mile Tim Davis Special Tactics Memorial March 59286 1Noninvasive Medical Technologies Supports 824 Mile Tim Davis Special Tactics Memorial March 59286 2Noninvasive Medical Technologies Supports 824 Mile Tim Davis Special Tactics Memorial March 59286 3Researchers Present a Novel Automated Efficient Environmental Disinfection Technology that Significantly Reduces C difficile VRE and MRSA Contamin 14436 1Researchers Present a Novel Automated Efficient Environmental Disinfection Technology that Significantly Reduces C difficile VRE and MRSA Contamin 14436 2Researchers Present a Novel Automated Efficient Environmental Disinfection Technology that Significantly Reduces C difficile VRE and MRSA Contamin 14436 3